These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1464513)
21. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent. Wang X; Feng Y; Ke T; Schabel M; Lu ZR Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467 [TBL] [Abstract][Full Text] [Related]
22. Coronary vasodilation without myocardial erection. Simultaneous haemodynamic, echocardiographic and arteriographic findings during adenosine and dipyridamole infusion. Beleslin BD; Ostojic M; Djordjevic-Dikic A; Nedeljkovic M; Stankovic G; Stojkovic S; Babic R; Stepanovic J; Saponjski J; Marinkovic J; Vasiljevic-Pokrajcic Z; Kanjuh V Eur Heart J; 1997 Jul; 18(7):1166-74. PubMed ID: 9243152 [TBL] [Abstract][Full Text] [Related]
25. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine. Vexler VS; Clément O; Brasch RC Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273 [No Abstract] [Full Text] [Related]
26. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174 [TBL] [Abstract][Full Text] [Related]
27. Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise. A role for adenosine. Symons JD; Firoozmand E; Longhurst JC Circ Res; 1993 Sep; 73(3):503-13. PubMed ID: 8348693 [TBL] [Abstract][Full Text] [Related]
28. Value and limitation of gadolinium-DTPA contrast enhancement in the early detection of acute canine myocardial infarction. Nishimura T; Yamada Y; Kozuka T; Nakatani T; Noda H; Takano H Am J Physiol Imaging; 1987; 2(4):181-5. PubMed ID: 3451771 [TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations. Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424 [TBL] [Abstract][Full Text] [Related]
30. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Van Rossum AC; Visser FC; Van Eenige MJ; Sprenger M; Valk J; Verheugt FW; Roos JP Am J Cardiol; 1990 Apr; 65(13):845-51. PubMed ID: 2321534 [TBL] [Abstract][Full Text] [Related]
33. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
34. Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI. Lüdemann L; Schmitt B; Podrabsky P; Schnackenburg B; Böck J; Gutberlet M Eur J Radiol; 2007 May; 62(2):247-56. PubMed ID: 17188443 [TBL] [Abstract][Full Text] [Related]
35. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values. Mahmod M; Piechnik SK; Levelt E; Ferreira VM; Francis JM; Lewis A; Pal N; Dass S; Ashrafian H; Neubauer S; Karamitsos TD J Cardiovasc Magn Reson; 2014 Nov; 16(1):92. PubMed ID: 25410203 [TBL] [Abstract][Full Text] [Related]
36. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Kuwatsuru R; Shames DM; Mühler A; Mintorovitch J; Vexler V; Mann JS; Cohn F; Price D; Huberty J; Brasch RC Magn Reson Med; 1993 Jul; 30(1):76-81. PubMed ID: 8371678 [TBL] [Abstract][Full Text] [Related]
37. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model. Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474 [TBL] [Abstract][Full Text] [Related]
38. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
39. Myocardial perfusion assessed by subsecond magnetic resonance imaging with a paramagnetic macromolecular contrast agent. Arteaga C; Canet E; Ovize M; Janier M; Revel D Invest Radiol; 1994 Jun; 29 Suppl 2():S54-7. PubMed ID: 7928271 [No Abstract] [Full Text] [Related]
40. AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals. Baxter AB; Melnikoff S; Stites DP; Brasch RC Invest Radiol; 1991 Dec; 26(12):1035-40. PubMed ID: 1722486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]